Welcome to the Working Group on New TB Drugs Blog

Save the Date: WGND Annual Meeting
Open Forum 4: Key Issues in Drug Development
From Citizen News Service: The Open Forum 4 on key issues in tuberculosis (TB) drug development is all set to begin in Addis Ababa, Ethiopia (18-19 August 2010). This Open Forum 4, will raise and address key issues in TB drug development, with a special focus on regulatory affairs. The Forum will include sessions on the current global TB drug development portfolio, key issues in the critical path to TB drug registration, designing pivotal trials, conducting registration trials in high TB burden countries, challenges in TB drug development for resistant disease and developing regimens containing multiple novel agents.
This Week in TB R&D – July 20, 2010

On Friday, July 16th, the fourth annual New England TB Symposium took place at the Broad Institute, in Cambridge, Massachusetts. The symposium was in collaboration with the US-Japan Cooperative Medical Sciences Program: 45th Tuberculosis and Leprosy Research Conference which preceded the symposium at the Broad from July 13-15th.
A brief synopsis of some of the symposium [...]
Event: Health Swaps in Sub-Saharan Africa
Event: Community Involvement in TB Drug Development: A roundtable discussion

Community engagement in TB drug research is growing practice, made possible by the fact that several new drug candidates are entering clinical trials. This roundtable will provide a forum for dialogue between researchers, community members, CBOs/NGOs, and advocates about methods for effective community engagement in TB research. Panelists representing several viewpoints will highlight successful practices for encouraging stakeholder involvement in research and discuss how communities can influence national policies and procedures to ensure the rapid adoption and roll-out of new TB regimens, once available.
GHC Conference: Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis
Register Now for Open Forum 4: Key Issues in TB Drug Development

Register Now for Open Forum 4: Key Issues in TB Drug Development.
August 18-19, 2010 | Addis Ababa, Ethiopia
The conference will address key issues in TB drug development, with a special focus on regulatory affairs. This upcoming event will highlight TB drug development challenges in light of new treatment advances and feature keynote addresses from thought leaders in the field of tuberculosis.
This week in TB R&D – 12 April 2010

On April 6th, the New York Academy of Sciences hosted a mini-symposium entitled ‘Tuberculosis: Novel Therapies through Knowledge of the Genetics of the Causative Agent.’ The five research scientists who presented were: William R. Jacobs, Jr. (Albert Einstein College of Medicine), Christopher Sassetti (University of Massachusetts Medical School), Dirk Schnappinger (Weill Cornell Medical College), Helena [...]










